2013•Zhongguo jiceng yiyaoRequires access

Clinical observation on ambroxol in the treatment of 50 children with pneumonia

Suying Liu

Open publisher page 0 citations

Abstract

Objective To investigate the effect of ambroxol hydrochloride in the treatment of children with pneumonia.Methods 100 children with pneumonia in our hospital were randomly divided into the treatment group and the control group,50 cases in each group.The control group was given conventional therapy,the treatment group was treated with ambroxol on the basis of the control group.The treatment effect was compared between the two groups.Results The total effective rate in treatment group was 92%,which was significantly higher than 72% in the control group(x2 =3.87,P < 0.05).CD4+,CD4+/CD8+ immune factor indexes in the treatment group were significantly higher than those in the control group,IgE was significantly lower than that in the control group(t =11.97,1.95,13.56,all P < 0.05).Extinction time of fever,pulmonary rales,cough and hospital stay in the treatment group were significantly less than those in the control group(t =2.93,5.82,3.56,7.71,all P < 0.05).The adverse reactions between the two groups had no significant difference (x2 =1.21,P > 0.05).Conclusion Ambroxol can enhance the cellular immune function in children with pneumonia,rapidly relieve clinical symptoms,improve the therapeutic effect,and have no adverse reaction. Key words: Ambroxol;  Pneumonia;  Child;  Immunologic factors;  Treatment outcome

About this research paper

What this paper is about

Objective To investigate the effect of ambroxol hydrochloride in the treatment of children with pneumonia.Methods 100 children with pneumonia in our hospital were randomly divided into the treatment group and the control group,50 cases in each group.The control group was given conventional therapy,the treatment group was treated with ambroxol on the basis of the control group.The treatment effect was compared between the two groups.Results The total effective rate in treatment group was 92%,which was significantly higher than 72% in the control group(x2 =3.87,P < 0.05).CD4+,CD4+/CD8+ immune factor indexes in the treatment group were significantly higher than those in the control group,IgE was significantly lower than that in the control group(t =11.97,1.95,13.56,all P < 0.05).Extinction time of fever,pulmonary rales,cough and hospital stay in the treatment group were significantly less than those in the control group(t =2.93,5.82,3.56,7.71,all P < 0.05).The adverse reactions between the two groups had no significant difference (x2 =1.21,P > 0.05).Conclusion Ambroxol can enhance the cellular immune function in children with pneumonia,rapidly relieve clinical symptoms,improve the therapeutic effect,and have no adverse reaction. Key words: Ambroxol;  Pneumonia;  Child;  Immunologic factors;  Treatment outcome

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of ambroxol hydrochloride in the treatment of children with pneumonia.Methods 100 children with pneumonia in our hospital were randomly divided into the treatment group and the control group,50 cases in each group.The control group was given conventional therapy,the treatment group was treated with ambroxol on the basis of the control group.The treatment effect was compared between the two groups.Results The total effective rate in treatment group was 92%,which was significantly higher than 72% in the control group(x2 =3.87,P < 0.05).CD4+,CD4+/CD8+ immune factor indexes in the treatment group were significantly higher than those in the control group,IgE was significantly lower than that in the control group(t =11.97,1.95,13.56,all P < 0.05).Extinction time of fever,pulmonary rales,cough and hospital stay in the treatment group were significantly less than those in the control group(t =2.93,5.82,3.56,7.71,all P < 0.05).The adverse reactions between the two groups had no significant difference (x2 =1.21,P > 0.05).Conclusion Ambroxol can enhance the cellular immune function in children with pneumonia,rapidly relieve clinical symptoms,improve the therapeutic effect,and have no adverse reaction. Key words: Ambroxol;  Pneumonia;  Child;  Immunologic factors;  Treatment outcome

Key concepts: Ambroxol, Medicine, Pneumonia, Treatment and control groups, Adverse effect, Internal medicine, Therapeutic effect, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on ambroxol in the treatment of 50 children with pneumonia — Research Paper | ScholarLens